Posted by Aimhigh > 2020-12-04 12:47 | Report Abuse

Anyone bought Hengyuan this morning? It's the next rocket. Gloves will be suppressed till don't know when

Posted by Kossan > 2020-12-04 13:37 | Report Abuse

Hengyuan Refining Company Bhd’s net loss narrowed in the third quarter ended Sept 30, 2020 to RM11.43 million from RM122.49 million a year earlier, due to higher revenue.

Loss per share fell to to 3.81 sen from 40.83 sen, the group said in a filing today.

Hengyuan said revenue for the quarter jumped 56% to RM3.23 billion from RM2.07 billion a year ago, as the refinery recorded sales volume of 10.7 million barrels.

Posted by Mat Cendana > 2020-12-04 17:23 | Report Abuse

The current trend may not be favourable for glove makers but I'm buying some units of Kossan anyway. This is one of the industries that are making big profits, and expected to continue doing so in the next few quarters at least. Therefore it's only prudent to have a glove counter or two in one's investment portfolio.

The only issue here is to try get the best price - something that one will only know what this "best" is after the fact. That is, have to wait for things to happen in the coming weeks and months. And since we can't possibly know right now, the best strategy may be to average, i.e. to buy at different times and price points.

Posted by Kossan > 2020-12-04 22:41 | Report Abuse

Have anyone read this Forbes report?

https://www.forbes.com/sites/leahrosenbaum/2020/06/12/willowbrook-scandal-hepatitis-experiments-hideous-truths-of-testing-vaccines-on-humans/?sh=4b90361d279c

This mRNA technology has never been approved for use in humans before, and some experts, including the nation’s top infectious disease doctor Tony Fauci suggested the U.K.’s authorization timetable was too hasty, while the U.S. Food and Drug Administration was taking more time.

Posted by gloveharicut > 2020-12-05 09:03 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-12-05-story-h1537418149-Can_GLOVES_maintain_their_performance.jsp

Posted by NPRA1985 > 2020-12-05 14:30 | Report Abuse

500 million vaccine doses in Q1 2021 closer to reality, says WHO

https://www.freemalaysiatoday.com/category/world/2020/12/05/500-million-vaccine-doses-in-q1-2021-closer-to-reality-says-who/

Posted by Slc1 > 2020-12-05 15:00 | Report Abuse

Dr Fauci said Pfizer n Moderna vaccine can only last for a couple of weeks. First dose can last for 28 days and then the 2nd jab can last for 7-10 days only . So how leh? Every 2 months have to jab the vaccine, like that die lah....

Posted by Cash Only > 2020-12-05 16:02 | Report Abuse

IF after glove counter added into index.. glove still falling. that means bursa has make big mistake. Any up of other industry will eventually drag down by glove counter. So I personally think Bursa is not stupid. Either glove will sustain at current level or easily having some growth over the next 2-3 years..otherwise I don't think Bursa will add them in.

Posted by Slc1 > 2020-12-05 18:59 | Report Abuse

https://www.thedenverchannel.com/news/national/coronavirus/dr-fauci-explains-why-coronavirus-vaccines-come-in-two-doses

Posted by chhn461 > 2020-12-05 23:59 | Report Abuse

Funds are dumping gloves in droves

Posted by supermxmx > 2020-12-06 14:17 | Report Abuse

CNBC - WHO warns reinfections may occur as data suggests antibodies wane
Recent data suggests people who were once infected with the coronavirus could be infected again as their antibody response wanes, Dr. Mike Ryan, executive director of the World Health Organization’s health emergencies program, said during a press briefing.
According to the U.S. Centers for Disease Control and Prevention, some Covid-19 reinfections are expected based on the agency’s prior experience with similar viruses. In late August, researchers in Hong Kong reported what appeared to be the first confirmed case of Covid reinfection. While rare, the WHO said at the time that reinfection could be possible.
Maria Van Kerkhove, head of the WHO’s emerging diseases and zoonosis unit, said that researchers are still trying to determine how long an antibody response lasts after someone is naturally infected with the virus.
“In some people, it may wane after a few months but we do get a good indication that natural infection immune response is lasting for some months,” Van Kerkhove said.

Posted by Kossan > 2020-12-06 17:03 | Report Abuse

How long will vaccine-induced immunity last? Looks like no one knows but those in Pharmaceutical is trying to make a quick buck here.

Fresh from Reuters

There is no quick way to determine how long immunity to the SARS-CoV-2 virus will last, and researchers will need to monitor this closely in the coming months and years.

There have been some reports of reinfection and falling antibody levels months after an initial bout of COVID-19, but it is still unclear how prevalent reinfection is. And there are signs that the immune system preserves a memory of coronavirus infection in the form of specialized memory cells that could kick into action rapidly if the virus is encountered again. And vaccines, Altmann says, are deliberately designed to provoke strong responses from the immune system.

Posted by TC > 2020-12-06 17:13 | Report Abuse

https://www.google.com.my/amp/s/www.malaymail.com/amp/news/money/2020/12/06/malaysian-rubber-glove-year-of-mixed-fortunes/1929278

Despite these setbacks, the industry is expected to extend its bullish sentiment in line with the deployment of the Covid-19 vaccine, which is set to boost the demand for rubber gloves by up to 18 billion pieces a year, assuming that 60 per cent of the world’s population of 7.5 billion people would get the vaccine in two doses annually.

Bank Islam Malaysia Bhd economist Adam Mohamed Rahim is also positive of the industry performance in view that demand growth would continue in 2022 as awareness towards health and personal hygiene are likely to remain prevalent as the general society is embracing the new normal.

“Therefore, demand for personal protective equipment, including gloves would help drive demand post-Covid-19. Expansion plans for major rubber glove makers are so far on track.

While the obstacles and challenges would continue, the industry, without a doubt, is in for another splendid year in 2021. — Bernama

Posted by Kossan > 2020-12-06 18:53 | Report Abuse

Fresh from Reuters

Overpromise by Pfizer- Pfizer says supply chain challenges contributed to slashed target for COVID-19 vaccine doses in 2020

https://www.google.com.my/amp/s/mobile.reuters.com/article/amp/idUKKBN28D3B9


The Health Ministry released a statement in response to the public’s inquiry regarding a recent Reuter’s report on 4 December.

The report claimed that the US pharmaceutical giant Pfizer has had challenges to their raw material supply chain which will result in reduced quantities for the first batch of their Covid-19 vaccine.

Posted by Vulture123 > 2020-12-06 22:11 | Report Abuse

Vaccines definitely on the way and can end the pandemic. There will even be numerous choices available in early 2021. For the sake of mankind and the return to normality, let’s hope that the effectiveness and efficacy is good. All of us should be wishing that the vaccines will work and be readily available soonest possible.

Posted by Vulture123 > 2020-12-06 22:27 | Report Abuse

Klang Valley SME businesses that already survived two protracted lockdown (MCO & CMCO) will not be able to survive another round of lockdown. Pandemic must taper off and end in 2021 so that borders can be reopened.

Posted by Kossan > 2020-12-07 08:16 | Report Abuse

Fresh from CNBC

Dr. Anthony Fauci says there's a chance coronavirus vaccine may not provide immunity for very long.

White House health advisor Dr. Anthony Fauci said he worries about the "durability" of a potential coronavirus vaccine, saying there's a chance it may not provide long-term immunity.
If Covid-19 acts like other coronaviruses, "it likely isn't going to be a long duration of immunity," Fauci, director of the National Institute of Allergy and Infectious Diseases, told JAMA Editor Howard Bauchner.

Posted by LiimInvest > 2020-12-07 10:55 | Report Abuse

KUALA LUMPUR (Dec 7): MY E.G. Services Bhd (MYEG) announced today that it has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei) to obtain Malaysian Halal certification for the Chinese biopharma company’s COVID-19 vaccine and to exclusively distribute the vaccine in Malaysia for a 3-year period.

In a statement today, MYEG said the two companies have signed a Memorandum of Understanding, agreeing to cooperate in conducting Phase 3 clinical trials of Zhifei’s vaccine in Malaysia and in achieving compliance to Halal status requirements to secure Halal certification from the Department of Islamic Development Malaysia (JAKIM).

MYEG said the commencement of Phase 3 trial will make Zhifei’s vaccine one of the first to undergo this final stage trial in Malaysia under the purview of the Ministry of Health.

Zhifei is a subsidiary of Chongqing Zhifei Biological Products Co., Ltd., which is listed on the Shenzhen Stock Exchange and has been engaged in the biological products industry since 2002, mainly the production of vaccines for human use. Zhifei is presently one of five Chinese companies conducting Phase 3 clinical trials of their COVID-19 vaccines in various parts of the world.

Upon successful completion of the Phase 3 trials, MYEG will be the sole distributor of the vaccine in Malaysia.

Since Nov 1, 2020, MYEG has been appointed by the Malaysian Ministry of Health to develop and operate the MySafeTravel digital health pass system to facilitate inbound travellers’ compliance to mandatory COVID-19 testing and quarantine requirements.

In addition, MYEG also operates a one-stop portal for the COVID-19 screening of workers in the country, which includes a data sharing collaboration with the Department of Labour of Peninsular Malaysia.

MYEG was last traded at RM1.81, valuing it at RM6.61 billion.

Posted by calvintaneng > 2020-12-07 14:48 | Report Abuse

Even if I assume the selling price for gloves is not increased for the whole financial year, all the glove stocks are selling at very low PE as shown on the table below:

Name Price Quarter EPS 4XEPS PE

Supermax Rm 8.29 Sept 30.58 Rm 1.22 6.8

CarePlus Rm 2.60 Sept 8.00 32 sen 8.1

Comfort Rm 3.73 Oct 10.30 41.3 sen 9.0

Top Glove Rm 6.65 Aug 15.95 63.8 sen 10.4

Kossan Rm 6.10 Sept 13.6 54.4 sen 11.2

Rubberex Rm 1.73 Sept 4.96 19.8 sen 18.8

Hartalega Rm 14.50 Sept 15.95 63.8 sen 22.7

Instead of selling my glove stocks, I should consider to buy more glove stocks, especially Supermax.

Calvin comments:

I think SUPERMAX has already done very well with ASP

I bought Supermax at Rm1.73 & sold all above Rm18 (after bonus Rm9.00) for 1,000% gain

NOW I THINK KOSSAN STILL A GOOD BUY AT RM5.88

Kossan has the highest Quality

Clean room Surgical Gloves & faces masks

Faithful to its customers thru thick & thin

Kossan does not take short cut but build up its business solidly and professionally

Its Top shareholders are great names. Among them is Eastspring Investment Fund

There are many new glove entrants

BUT LOYAL HOSPPITALS, SURGEONS & DOCTORS WILL STILL STICK WITH KOSSAN FOR THE HIGHEST QUALITY

A Surgeon cannot risk his life using untested & unproven medical gloves out there

Like a brand name KOSSAN is well known for HIGH QUALITY & SAFETY

Nobody will buy cheap roadside medicine from pasar malam

So no surgeon will be gloves from new unknown glove wannabees
07/12/2020 2:48 PM

Posted by JimYeoh > 2020-12-07 15:26 | Report Abuse

Based on kyy's calculation and extrapolate to Salcon with 3 billion gloves and 51% ownership and 1 billion share issued, the earnings per share is 8.8 cents and at p.e 15, the fair price is 1.33

Posted by Shines > 2020-12-07 19:21 | Report Abuse

Everyday Gostan only Kossan

Posted by Ukga > 2020-12-07 20:05 | Report Abuse

We all know high profit for gloves will continue into 2021 and might translate into better dividends payout. But,,, investors sentiment will dictate their share prices. Enjoy share trading and stay safe.

Posted by Mabel > 2020-12-07 21:36 | Report Abuse

By end Dec 2020, 100million Covid cases.

What do u think of glove demand? Reduce or increase?

By mid 2021, less than 1% of world population got vaccinated.

What do u think of glove demand? Reduce or increase?

By end 2022, less than 10% of world population got vaccinated.

What do u think of glove demand? Reduce or increase?

By end 2025, 90% of world population got vaccinated.

When can the world achieve herd immunity? We need 2 dose.

What do u think of glove demand? Reduce or increase?

Glove is like your clothing. U must wear it everyday to protect yourself from the environment.

U think demand will reduce? I don't think so.

Posted by Mabel > 2020-12-07 21:41 | Report Abuse

Every stocks has it's life cycle. Right now volume is small for Gloves due to rotational play and series of bad news. Don't drain your energy. Come back when Gloves is ready to dance..

Today nothing the Naysayers said will make Mabel angry...

All Mabel 11 Fossil Fuel Battleships and 11 Biodiesel Fuel Plantation are up cruising on Full Speed...

As an example, Mabel Fossil Fuel Battleship Armada and Bio Fuel TDM Plantation which is equipped with Medical Centres are both cruising at high speed with both exceeding 125 million shares traded.

Let see which one will break 40 sen first..

Meow Meow Meow

Posted by Mabel > 2020-12-07 21:43 | Report Abuse

#calvintaneng Even if I assume the selling price for gloves is not increased for the whole financial year, all the glove stocks are selling at very low PE as shown on the table below:

Name Price Quarter EPS 4XEPS PE

Supermax Rm 8.29 Sept 30.58 Rm 1.22 6.8

CarePlus Rm 2.60 Sept 8.00 32 sen 8.1

Comfort Rm 3.73 Oct 10.30 41.3 sen 9.0

Top Glove Rm 6.65 Aug 15.95 63.8 sen 10.4

Kossan Rm 6.10 Sept 13.6 54.4 sen 11.2

Rubberex Rm 1.73 Sept 4.96 19.8 sen 18.8

Hartalega Rm 14.50 Sept 15.95 63.8 sen 22.7

Instead of selling my glove stocks, I should consider to buy more glove stocks, especially Supermax.

Calvin comments:

I think SUPERMAX has already done very well with ASP

I bought Supermax at Rm1.73 & sold all above Rm18 (after bonus Rm9.00) for 1,000% gain

NOW I THINK KOSSAN STILL A GOOD BUY AT RM5.88

Kossan has the highest Quality

Clean room Surgical Gloves & faces masks

Faithful to its customers thru thick & thin

Kossan does not take short cut but build up its business solidly and professionally

Its Top shareholders are great names. Among them is Eastspring Investment Fund

There are many new glove entrants

BUT LOYAL HOSPPITALS, SURGEONS & DOCTORS WILL STILL STICK WITH KOSSAN FOR THE HIGHEST QUALITY

A Surgeon cannot risk his life using untested & unproven medical gloves out there

Like a brand name KOSSAN is well known for HIGH QUALITY & SAFETY

Nobody will buy cheap roadside medicine from pasar malam

So no surgeon will be gloves from new unknown glove wannabees

Calvin is a very smart man..

Mabel always adore smart man..

Meow Meow Meow

Posted by Kossan > 2020-12-08 00:13 | Report Abuse

Macquarie Equities Research (MQ Research) summarised a presentation held by the Kossan’s Executive Director in the ASEAN Conference. Strong glove demand is reaffirmed as enquiries for spot orders continue to rise with Kossan’s observation of a shortage in the market currently. Kossan shared its plan to increase the average selling price (ASP) and spot prices in December and November while sharing its view of that an oversupply may not be likely to happen in 2021 despite having a lot of new entrants into the sector. MQ Research maintains Kossan’s target price at RM30.40.
Read on for more.

Posted by LiimInvest > 2020-12-08 08:43 | Report Abuse

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

PETALING JAYA: My E.G. Services Bhd has entered into a memorandum of understanding (MoU) with Anhui Zhifei Longcom Biopharmaceutical Co Ltd to conduct phase three clinical trials and subsequent commercialisation of its Covid-19 vaccine in Malaysia.

MyEG will be the sole distributor of the vaccine in Malaysia upon successful completion of the phase three trials, it said in a statement.

Under the terms of the contract, the companies will strive to achieve compliance to halal status requirements to secure halal certification from the Department of Islamic Development Malaysia and ensure increased acceptance from the global Muslim population.

Zhifei is a subsidiary of Chongqing Zhifei Biological Products Co Ltd which is listed on the Shenzhen Stock Exchange and has been engaged in the biological products industry since 2002, particularly the production of vaccines for human use.

It is presently one of five Chinese companies conducting phase three clinical trials of the Covid-19 vaccine in various parts of the world.

The MoU is valid for three years from the date of signing and may be further extended upon mutual agreement.

The contract is not expected to have any material effect on the net asset per share and gearing of the company for financial year 2020 (FY20) but is expected to contribute positively in FY21 upon successful completion of the phase three trials and commercialisation of the vaccine.

Posted by LiimInvest > 2020-12-08 08:50 | Report Abuse

“The government’s deal is only with Pfizer and Covax, and does not go through any third party or middleman,” he added.

https://www.malaymail.com/news/malaysia/2020/12/07/allocation-for-mosti-approved-minister-says-govts-covid-19-vaccine-deal-onl/1929671

Posted by super_newbie > 2020-12-08 11:40 | Report Abuse

31/12/19
Share Price RM4.65
NOSH 1,278,936
Market Cap = 4.65 * 1,278,936 = RM5,947 Million

08/12/20
Share Price RM6.00
NOSH 2,557,872
Market Cap = 6.00 * 2,557,872 = RM15,347 Million

Market Cap increased = (15,347/5,947) - 1 * 100% = 158%
T4Q Net profit increased = 171%

# Market Cap laggard of 13%


Estimated PATAMI of RM780m for quarter ending December as management guidance higher than expected ASP increment at 75% QoQ.

By next quarter, the T4Q net profit increase would be +489%. Has market recognize this profit growth compare to current 158% increased?

Posted by Mat Cendana > 2020-12-08 11:50 | Report Abuse

@Mabel 07/12/2020 9:36 PM What do u think of glove demand? Reduce or increase?
...
For next year at least, I believe the worst-case is that the demand plateaus. With these gloves companies, their orders are stacked until the end of 2021. That's a very comfortable position to be in. Which is why an investor must have at least one gloves counter in his portfolio. And the price correction yesterday had provided a good opportunity to buy or add.

Among the more immediate concerns now are the price of raw materials, labour and the nagging possibility of a windfall tax. But the first two aren't unique problems in business and something which these companies have been handling for years. As compared to most others, glove companies are in a very comfortable position.

This price correction will level off sooner rather than later. I believe institutional buyers would want to have a certain percentage of their investment portfolio in companies that not only can weather the Covid-19 environment but in fact are doing well. Gloves are clearly in this category. And December is the "window dressing period" when prices of dividend counters tend to go up.

Posted by New994 > 2020-12-08 14:40 | Report Abuse

Kossan and harta follow the superman and topp

Posted by hng33 > 2020-12-08 14:55 | Report Abuse

use all margin, bought all kossan at 6.00

Posted by ks5S > 2020-12-08 15:40 | Report Abuse

welcome on board. i also bought .Let kossan reach 6.50

Posted by super_newbie > 2020-12-08 15:53 | Report Abuse

Price controlled at below RM6.00.

Posted by Slc1 > 2020-12-08 16:00 | Report Abuse

Wait till epf sell all only can move.

Posted by WeLoveSarawak > 2020-12-08 16:04 | Report Abuse

kossan and hartalega both are like tortoises in a 100m sprint

Posted by Mat Cendana > 2020-12-08 17:39 | Report Abuse

When compared to Supermax and TopGlove, Kossan tends to be `slow, lethargic'. Its shares don't get chased like those two whenever there's a rebound. Investors will have to live with this characteristic. But who's to say it won't become like PETRONM in the coming weeks. This one too tends to be slow... and then suddenly becomes a rocket.

Posted by Mat Cendana > 2020-12-08 17:47 | Report Abuse

I'm also considering one probability based on a report I had read somewhere (sorry, can't remember where exactly) - of something sweet for shareholders. Specifically for the controlling shareholders, but which we the ikan bilis will benefit too since are also shareholders.

The #1 shareholder is Kossan Sdn Bhd. Then those other investment vehicles listed among the Top 10 comprising Tan Sri, his family, relatives and close friends. They might not want to sell their shares (and then buy what with the proceeds?) including with the bonus units. But they'd want "spending money" for whatever activities they may have in mind. One way to fulfil this, i.e. "Having your cake and eating it too" - a special dividend. This way everyone gets some money while still having his units.

This is just speculation of course. But with Kossan churning in exceptional income this year, a special dividend is definitely possible.

Posted by Mat Cendana > 2020-12-08 17:56 | Report Abuse

@hng33 use all margin, bought all kossan at 6.00
08/12/2020 2:55 PM
...
This is very encouraging. Trader hng33 has been around at i3investor from since several years ago. Always open with his buys and sells - sticking his neck out by stating in public his entry and exit points. Unlike wannabes who'd gloat of `making big profits' only after the fact. And keeping quiet about their losses. Anyway hng33 is more often right than wrong with his short-term trades. I'm hoping he's right with this one.

But even if he's wrong, I'm sticking with Kossan for at least a while. Adding more should there be significant drops. Because this is a great business to be in during times like this.

Posted by MYinvestor > 2020-12-08 18:39 | Report Abuse

why kossan is very hard to be up

Posted by mamatede > 2020-12-08 19:39 | Report Abuse

https://www.youtube.com/watch?v=ZXvtzer4hB4&ab_channel=CGTN

If you watch this video on coverage for the vaccine given in UK to the first patient. The nurse not even use any gloves but bare hands. Guess we dont need any gloves in giving vaccine ... this misconception need to be address.

Lai lai share this facts.

Posted by jeremylin > 2020-12-08 21:21 | Report Abuse

https://www.bbc.co.uk/news/uk-northern-ireland-55216347

Posted by jeremylin > 2020-12-08 21:22 | Report Abuse

The nurse receive first jab vaccine got use glove during injection

Posted by jeremylin > 2020-12-08 21:34 | Report Abuse

tomorrow kossan up 6.5

Posted by ks5S > 2020-12-08 22:10 | Report Abuse

tomorrow kossan engine start firing
today only engine warm up

Posted by Mr.Sm Invest123 > 2020-12-08 22:38 | Report Abuse

分析：联昌国际投行研究

目标价：2.50令吉

最新进展

MyEG（MYEG，0138，主板科技股）与中国安徽智飞龙科马生物制药有限公司合作，协助者的冠病疫苗获取大马清真认证，并成为我国独家分销商。

双方签署了解备忘录，合作在我国进行后者疫苗的第三阶段临床试验，并遵守清真要求，以获得回教发展局（JAKIM）的清真认证。

Posted by aoisky > 2020-12-08 22:39 | Report Abuse

why tomorrow engine firing? any good news ?

Posted by Mr.Sm Invest123 > 2020-12-08 22:48 | Report Abuse

https://www.reuters.com/article/us-health-coronavirus-fda-pfizer-idUSKBN28I1RX

Posted by Algorithm_trading > 2020-12-09 10:39 | Report Abuse

engine firing backwards so far....

Posted by ruhaizat69 > 2020-12-09 10:42 | Report Abuse

Run